Cynosure Group LLC Sells 571 Shares of Exponent, Inc. (NASDAQ:EXPO)

Cynosure Group LLC reduced its position in Exponent, Inc. (NASDAQ:EXPO) by 8.2% during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 6,416 shares of the business services provider’s stock after selling 571 shares during the period. Cynosure Group LLC’s holdings in Exponent were worth $572,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently modified their holdings of the company. Private Trust Co. NA boosted its stake in Exponent by 129.8% in the fourth quarter. Private Trust Co. NA now owns 278 shares of the business services provider’s stock valued at $25,000 after acquiring an additional 157 shares in the last quarter. Atala Financial Inc purchased a new position in Exponent during the 4th quarter worth $25,000. Westside Investment Management Inc. purchased a new position in Exponent during the 3rd quarter worth $26,000. Tortoise Investment Management LLC increased its position in Exponent by 76.7% during the 4th quarter. Tortoise Investment Management LLC now owns 440 shares of the business services provider’s stock valued at $39,000 after buying an additional 191 shares in the last quarter. Finally, Trust Co. of Vermont purchased a new stake in Exponent in the fourth quarter valued at about $45,000. Hedge funds and other institutional investors own 92.37% of the company’s stock.

Exponent Stock Performance

Shares of EXPO stock opened at $80.78 on Wednesday. The firm has a market capitalization of $4.11 billion, a price-to-earnings ratio of 38.10 and a beta of 0.77. The stock’s 50-day simple moving average is $86.30 and its 200-day simple moving average is $95.27. Exponent, Inc. has a fifty-two week low of $77.30 and a fifty-two week high of $115.75.

Exponent (NASDAQ:EXPO) last posted its quarterly earnings data on Thursday, February 6th. The business services provider reported $0.46 EPS for the quarter, topping the consensus estimate of $0.40 by $0.06. Exponent had a net margin of 19.52% and a return on equity of 27.27%. During the same quarter in the prior year, the company earned $0.41 earnings per share. As a group, equities analysts forecast that Exponent, Inc. will post 1.98 earnings per share for the current year.

Insider Transactions at Exponent

In related news, VP Richard Reiss sold 1,736 shares of the stock in a transaction that occurred on Wednesday, February 26th. The shares were sold at an average price of $85.93, for a total value of $149,174.48. Following the transaction, the vice president now owns 1,800 shares in the company, valued at approximately $154,674. This represents a 49.10 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Company insiders own 2.10% of the company’s stock.

About Exponent

Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.